Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "M03" (92)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Suxamethonium (M03AB01) 3 products
WHO-DDD
DrugBank.ca
IP
Succinolin 100 mg/2 mL
100 x 2 ml
PR
PR
k.A.
Injection solution: Suxamethonii Chloridum Anhydricum 100mg / 2ml
Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte
●
B
FB
G
IP
Succinolin 100 mg/2 mL
10 x 2 ml
2.25
11.70
10 %
Injection solution: Suxamethonii Chloridum Anhydricum 100mg / 2ml
Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte
B / SL
FB
G
IP
Lysthenon siccum
10 Stechampullen
PR
60.30
k.A.
Injection preparation: Suxamethonii Chloridum Anhydricum 500 mg
Nycomed Pharma AG
B
FB
G
Atracurium (M03AC04) 5 products
WHO-DDD
DrugBank.ca
IP
Atracurium Labatec 10
mg/ml
5 1 ampoule(s) à 2.5 ml
PR
PR
k.A.
: Atracurii Besilas 10 mg/ml
Labatec Pharma SA
B
FB
G
IP
Atracurium Labatec 10
mg/ml
5 1 ampoule(s) à 5 ml
PR
PR
k.A.
: Atracurii Besilas 10 mg/ml
Labatec Pharma SA
B
FB
G
IP
Tracrium 10mg/ml
5 1 ampoule(s) à 2.5 ml
PR
PR
k.A.
Infusion solution: Atracurii Besilas 10 mg/ml
Aspen Pharma Schweiz
GmbH
●
B
FB
G
IP
Tracrium 10mg/ml
5 1 ampoule(s) à 5 ml
PR
PR
k.A.
Infusion solution: Atracurii Besilas 10 mg/ml
Aspen Pharma Schweiz
GmbH
●
B
FB
G
IP
Tracrium 10mg/ml
100 1 ampoule(s) à 2.5 ml
PR
PR
k.A.
Infusion solution: Atracurii Besilas 10 mg/ml
Aspen Pharma Schweiz
GmbH
B
FB
G
Rocuronium Bromide (M03AC09) 8 products
WHO-DDD
IP
Esmeron 50mg/5ml
Injektionslösung
10 Durchstechflasche(n)
PR
PR
k.A.
Rocuronii Bromidum 50mg / 5ml
MSD Merck Sharp &
Dohme AG
B
FB
G
IP
Esmeron 100mg/10ml
Injektionslösung
10 Durchstechflasche(n)
PR
311.20
k.A.
Rocuronii Bromidum 100mg / 10ml
MSD Merck Sharp &
Dohme AG
B
FB
G
Rocuronium Aguettant 10
mg/ml
10 x 5 ml
PR
PR
k.A.
: Rocuronii Bromidum 50mg / 5ml
Aguettant Suisse SA
B
FB
G
IP
Rocuronium Fresenius 50 mg / 5 ml
10
PR
PR
k.A.
Injection solution: Rocuronii Bromidum 50mg / 5ml
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
Rocuronium Fresenius 100 mg / 10 ml
10
PR
PR
k.A.
Injection solution: Rocuronii Bromidum 100mg / 10ml
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
Rocuronium Labatec 50 mg/ 5 mL
10 1 Durchstechflasche(n) à 5 ml
PR
PR
k.A.
Injection solution: Rocuronii Bromidum 50mg / 5ml
Labatec Pharma SA
B
FB
G
IP
Rocuronium Fresenius 50 mg / 5 ml
5
PR
PR
k.A.
Injection solution: Rocuronii Bromidum 50mg / 5ml
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
Rocuronium Fresenius 100 mg / 10 ml
5
PR
PR
k.A.
Injection solution: Rocuronii Bromidum 100mg / 10ml
Fresenius Kabi
(Schweiz) AG
B
FB
G
Mivacurium Chloride (M03AC10) 2 products
WHO-DDD
IP
Mivacron
5 x 5 ml
PR
PR
k.A.
Injection solution: Mivacurium 2 mg/ml
Aspen Pharma Schweiz
GmbH
●
A
FB
G
IP
Mivacron
5 x 10 ml
PR
PR
k.A.
Injection solution: Mivacurium 2 mg/ml
Aspen Pharma Schweiz
GmbH
A
FB
G
Cisatracurium (M03AC11) 2 products
WHO-DDD
DrugBank.ca
IP
Nimbex 2 mg/ml
5 ampoule(s)
PR
PR
k.A.
Injection solution: Cisatracurii Besilas 2.68 mg/ml
Aspen Pharma Schweiz
GmbH
B
FB
G
IP
Nimbex 2 mg/ml
5 ampoule(s)
PR
PR
k.A.
Injection solution: Cisatracurii Besilas 2.68 mg/ml
Aspen Pharma Schweiz
GmbH
B
FB
G
Botulinum Toxin (M03AX01) 24 products
WHO-DDD
L
IP
Botox 50 Allergan-
Einheiten
2
201.70
235.80
10 %
Dry substance: Toxinum Botulinicum A 50 U
AbbVie AG
A / SL
FB
G
L
IP
Botox 100 Allergan-
Einheiten
Durchstechflasche(n)
201.70
235.80
10 %
Dry substance: Toxinum Botulinicum A 100 U
AbbVie AG
A / SL
FB
G
L
IP
Botox 100 Allergan-
Einheiten
2 Durchstechflasche(n)
403.40
455.15
10 %
Dry substance: Toxinum Botulinicum A 100 U
AbbVie AG
A / SL
FB
G
L
IP
Dysport 500U
Flasche(n)
302.55
345.45
10 %
Ipsen Pharma Schweiz
GmbH
A / SL
FB
G
L
IP
Dysport 300U
Flasche(n)
183.74
216.25
10 %
Ipsen Pharma Schweiz
GmbH
A / SL
FB
G
L
IP
Xeomin 50 LD50-Einheiten
Durchstechflasche(n)
98.66
123.70
10 %
Dry substance: Toxinum Botulinicum a (150 Kda) 50 UI
Merz Pharma (Schweiz) AG
A / SL
FB
G
L
IP
Xeomin 100 LD50-Einheiten
Durchstechflasche(n)
196.38
230.00
10 %
Dry substance: Toxinum Botulinicum a (150 Kda) 100 UI
Merz Pharma (Schweiz) AG
A / SL
FB
G
IP
Alluzience
PR
PR
k.A.
Future Health Pharma
GmbH
A
FB
G
IP
Alluzience
2
PR
PR
k.A.
Future Health Pharma
GmbH
A
FB
G
IP
Azzalure
2 Durchstechflasche(n)
PR
PR
k.A.
Future Health Pharma
GmbH
A
FB
G
IP
Bocouture 50 LD50-
Einheiten
Durchstechflasche(n)
PR
PR
k.A.
Dry substance: Toxinum Botulinicum a (150 Kda) 50 U
Merz Aesthetics
(Schweiz) AG
A
FB
G
IP
Bocouture 100 LD50-
Einheiten
PR
PR
k.A.
Dry substance: Toxinum Botulinicum a (150 Kda) 100 U
Merz Aesthetics
(Schweiz) AG
A
FB
G
IP
Relfydess 150 units/ 1,5 ml
PR
PR
k.A.
Injection solution: Toxinum Botulinicum a (Stirpis I01) 150U. / 1.5ml
Ipsen Pharma Schweiz
GmbH
A
FB
G
IP
Relfydess 150 units/ 1,5 ml
10
PR
PR
k.A.
Injection solution: Toxinum Botulinicum a (Stirpis I01) 150U. / 1.5ml
Ipsen Pharma Schweiz
GmbH
A
FB
G
IP
Vistabel
Durchstechflasche(n)
PR
PR
k.A.
Dry substance: Toxinum Botulinicum A 100 U
AbbVie AG
A
FB
G
IP
Azzalure
Durchstechflasche(n)
PR
PR
k.A.
Future Health Pharma
GmbH
A
FB
G
IP
Dysport 500U
2 Flasche(n)
PR
PR
k.A.
Ipsen Pharma Schweiz
GmbH
A
FB
G
IP
Dysport 300U
2 Flasche(n)
PR
PR
k.A.
Ipsen Pharma Schweiz
GmbH
A
FB
G
IP
Letybo 50 units
PR
PR
k.A.
Dry substance: Toxinum Botulinicum a (Stirpis Cbfc26) 50 U
Medius AG
A
FB
G
IP
Letybo 50 units
2
PR
PR
k.A.
Dry substance: Toxinum Botulinicum a (Stirpis Cbfc26) 50 U
Medius AG
A
FB
G
IP
Letybo 50 units
2
PR
PR
k.A.
Dry substance: Toxinum Botulinicum a (Stirpis Cbfc26) 50 U
Medius AG
A
FB
G
IP
Letybo 50 units
6
PR
PR
k.A.
Dry substance: Toxinum Botulinicum a (Stirpis Cbfc26) 50 U
Medius AG
A
FB
G
Nuceiva 50 Units
PR
PR
k.A.
Dry substance: Toxinum Botulinicum a (Stirpis Kcdc) 50 U
PLX Healthcare
Services (Schweiz)
GmbH
A
FB
G
IP
Xeomin 200 LD50-Einheiten
PR
PR
k.A.
Dry substance: Toxinum Botulinicum a (150 Kda) 200 UI
Merz Pharma (Schweiz) AG
A
FB
G
Methocarbamol (M03BA03) 10 products
WHO-DDD
DrugBank.ca
IP
CI
Metoflex 750 mg
50
PR
PR
k.A.
Tablets: Methocarbamolum 750 mg
Labatec Pharma SA
B
FB
G
IP
CI
Metoflex 750 mg
10
PR
PR
k.A.
Tablets: Methocarbamolum 750 mg
Labatec Pharma SA
B
FB
G
IP
CI
Metoflex 750 mg
10
PR
PR
k.A.
Coated tablets: Methocarbamolum 750 mg
Labatec Pharma SA
B
FB
G
IP
CI
Metoflex 750 mg
50
PR
PR
k.A.
Coated tablets: Methocarbamolum 750 mg
Labatec Pharma SA
B
FB
G
IP
CI
Metoflex 750 mg
100
PR
PR
k.A.
Tablets: Methocarbamolum 750 mg
Labatec Pharma SA
B
FB
G
IP
CI
Metoflex 750 mg
100
PR
PR
k.A.
Coated tablets: Methocarbamolum 750 mg
Labatec Pharma SA
B
FB
G
IP
CI
Orthoton 750 mg
50
PR
PR
k.A.
Coated tablets: Methocarbamolum 750 mg
Recordati AG
B
FB
G
IP
CI
Orthoton 750 mg
100
PR
PR
k.A.
Coated tablets: Methocarbamolum 750 mg
Recordati AG
B
FB
G
IP
Orthoton 1500 mg
48
PR
PR
k.A.
Coated tablets: Methocarbamolum 1500 mg
Recordati AG
B
FB
G
IP
Orthoton 1500 mg
96
PR
PR
k.A.
Coated tablets: Methocarbamolum 1500 mg
Recordati AG
B
FB
G
Baclofen (M03BX01) 18 products
WHO-DDD
DrugBank.ca
IP
CI
Lioresal 10 mg
-
T
50 Tablet(s)
9.01
18.90
10 %
Tablets: Baclofenum 10 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
IP
CI
Lioresal 10 mg
-
T
200 Tablet(s)
36.04
55.15
10 %
Tablets: Baclofenum 10 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
IP
CI
Lioresal 25 mg
50 Tablet(s)
17.82
35.60
10 %
Tablets: Baclofenum 25 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Lioresal intrathecal 10
mg/20 mL
ampoule(s)
71.39
94.05
10 %
: Baclofenum 10mg / 20ml
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Lioresal intrathecal 10
mg/5 mL
ampoule(s)
71.39
94.05
10 %
: Baclofenum 10mg / 5ml
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
IP
CI
Baclocalm 10 mg
50
7.21
17.10
10 %
Tablets: Baclofenum 10 mg
Labatec Pharma SA
B / SL / SG
FB
G
IP
CI
Baclocalm 10 mg
200
28.84
47.80
10 %
Tablets: Baclofenum 10 mg
Labatec Pharma SA
B / SL / SG
FB
G
IP
Baclocalm 25 mg
50
14.26
31.90
10 %
Tablets: Baclofenum 25 mg
Labatec Pharma SA
B / SL / SG
FB
G
L
IP
Baclofen Intrathecal
Sintetica 10mg/20ml
20 ml
60.00
81.65
10 %
Injection solution: Baclofenum 10mg / 20ml
Sintetica SA
B / SL / SG
FB
G
L
IP
Baclofen Intrathecal
Sintetica 10mg/20ml
5 1 ampoule(s) à 20 ml
300.00
342.70
10 %
Injection solution: Baclofenum 10mg / 20ml
Sintetica SA
B / SL / SG
FB
G
L
IP
Baclofen Intrathecal
Sintetica 10mg/5ml
10 1 ampoule(s) à 5 ml
600.00
668.95
10 %
Injection solution: Baclofenum 10mg / 5ml
Sintetica SA
B / SL / SG
FB
G
L
IP
Baclofen Intrathecal
Sintetica 10mg/5ml
10 x 5 ml
600.00
668.95
10 %
Injection solution: Baclofenum 10mg / 5ml
Sintetica SA
B / SL / SG
FB
G
IP
Baclofen Intrathecal
Sintetica 0.05mg/1ml
10 1 ampoule(s) à 1 ml
PR
PR
k.A.
Injection solution: Baclofenum
Sintetica SA
B
FB
G
IP
Baclofen Sintetica
Intrathecal 40mg/20ml
ampoule(s) à 20 ml
PR
PR
k.A.
Injection solution: Baclofenum 2 mg/ml
Sintetica SA
B
FB
G
IP
Baclofen Sintetica
Intrathecal 40mg/20ml
20 ml
PR
PR
k.A.
Injection solution: Baclofenum 2 mg/ml
Sintetica SA
B
FB
G
IP
CI
Lioresal intrathecal 0,05
mg/1 mL
5 ampoule(s)
PR
PR
k.A.
: Baclofenum 50 µg/ml
Novartis Pharma
Schweiz AG
B
FB
G
IP
CI
Liohem 10 mg
50
PR
PR
k.A.
Tablets: Baclofenum 10 mg
Hemony Pharmaceutical
Switzerland GmbH
B
FB
G
IP
Liohem 25 mg
50
PR
PR
k.A.
Tablets: Baclofenum 25 mg
Hemony Pharmaceutical
Switzerland GmbH
B
FB
G
Tizanidine (M03BX02) 11 products
WHO-DDD
DrugBank.ca
IP
CI
Sirdalud 2 mg
-
T
30 Tablet(s)
5.76
15.45
10 %
Tablets: Tizanidinum 2 mg
Sandoz
Pharmaceuticals AG
●
B / SL / SO
FB
G
IP
CI
Sirdalud 2 mg
-
T
100 Tablet(s)
16.52
34.20
10 %
Tablets: Tizanidinum 2 mg
Sandoz
Pharmaceuticals AG
●
B / SL / SO
FB
G
IP
CI
Sirdalud 4 mg
-
T
14 Tablet(s)
5.12
14.65
10 %
Tablets: Tizanidinum 4 mg
Sandoz
Pharmaceuticals AG
●
B / SL / SO
FB
G
IP
CI
Sirdalud 4 mg
-
T
30 Tablet(s)
9.10
19.00
10 %
Tablets: Tizanidinum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SO
FB
G
IP
CI
Sirdalud 4 mg
-
T
100 Tablet(s)
28.90
47.50
10 %
Tablets: Tizanidinum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SO
FB
G
IP
CI
Tizanidin axapharm 2 mg
30
4.61
14.25
10 %
Tablets: Tizanidinum 2 mg
axapharm ag
B / SL / SG
FB
G
IP
CI
Tizanidin axapharm 2 mg
100
13.22
30.80
10 %
Tablets: Tizanidinum 2 mg
axapharm ag
B / SL / SG
FB
G
IP
Tizanidin axapharm 4 mg
10
2.93
12.40
10 %
Tablets: Tizanidinum 4 mg
axapharm ag
B / SL / SG
FB
G
IP
Tizanidin axapharm 4 mg
30
7.28
17.15
10 %
Tablets: Tizanidinum 4 mg
axapharm ag
B / SL / SG
FB
G
IP
Tizanidin axapharm 4 mg
100
23.12
41.55
10 %
Tablets: Tizanidinum 4 mg
axapharm ag
B / SL / SG
FB
G
IP
CI
Sirdalud MR 6 mg
-
T
30 Capsule(s)
14.89
32.60
10 %
Capsules: Tizanidinum 6 mg
Sandoz
Pharmaceuticals AG
B / SL
FB
G
Tolperisone (M03BX04) 4 products
WHO-DDD
IP
CI
Mydocalm mite
30 Tablet(s)
6.26
16.05
10 %
Coated tablets: Tolperisoni Hydrochloridum 50 mg
Labatec Pharma SA
B / SL
FB
G
IP
Mydocalm
30 Tablet(s)
14.21
31.85
10 %
Coated tablets: Tolperisoni Hydrochloridum 150 mg
Labatec Pharma SA
B / SL
FB
G
IP
Mydocalm
100 Tablet(s)
39.78
59.70
10 %
Coated tablets: Tolperisoni Hydrochloridum 150 mg
Labatec Pharma SA
B / SL
FB
G
L
IP
Mydocalm
250 Tablet(s)
98.73
123.80
10 %
Coated tablets: Tolperisoni Hydrochloridum 150 mg
Labatec Pharma SA
B / SL
FB
G
Dantrolene (M03CA01) 5 products
WHO-DDD
DrugBank.ca
IP
Agilus 120 mg
6
PR
PR
k.A.
Dry substance: Dantrolenum Natricum Hemiheptahydricum 120 mg
Norgine AG
B
FB
G
IP
CI
Dantamacrin 25 mg
50
PR
PR
k.A.
Capsules: Dantrolenum Natricum Hemiheptahydricum 25 mg
Norgine AG
B
FB
G
IP
CI
Dantamacrin 50 mg
-
T
50 Capsule(s)
23.60
43.45
k.A.
Capsules: Dantrolenum Natricum Hemiheptahydricum 50 mg
Norgine AG
B
FB
G
IP
Dantrolen i.v.
12
PR
PR
k.A.
Norgine AG
B
FB
G
IP
Dantrolen i.v.
3 x 12
PR
PR
k.A.
Norgine AG
B
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
